Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
about
Impact of Age and Sex on QT Prolongation in Patients Receiving PsychotropicsQTc prolongation by psychotropic drugs and the risk of Torsade de PointesDrug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reportsPrevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.Evaluation of a QT nomogram for risk assessment after antidepressant overdose.Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010.Clinical use of antidepressant therapy and associated cardiovascular riskThe Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.Detailed analysis of the impact of age on the QT interval.Citalopram and cardiac toxicity.Benefits and pitfalls of cardiovascular medication in seniors.Antidepressant and QT interval prolongation, how should we look at this issue? Focus on citalopram.QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation.The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram.High prevalence of risk factors in elderly patients using drugs associated with acquired torsades de pointes chronically in Colombia.Molecular Basis of Hypokalemia-Induced Ventricular Fibrillation.Impact of Pharmacist Intervention on Electrocardiogram Monitoring of Pediatric Patients on Multiple QTc Interval-Prolonging Medications.Comprehensive review of cardiovascular toxicity of drugs and related agents.Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children.Approach to initiating QT-prolonging oncology drugs in the ambulatory setting.Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring.Life-threatening cardiac arrhythmias due to drug-induced QT prolongation : A retrospective study over 6 years from a medical intensive care unit.A comparative study of QT prolongation with serotonin reuptake inhibitors.
P2860
Q26801837-205D6BFA-2477-45BC-9AAE-48021B2C16F0Q27015763-E85F6633-0771-4354-996F-31CF31D1395CQ33661027-7319CCEE-A9ED-46E9-8B6F-D2BFF75B1E96Q34016220-CA2E87FC-8FC4-4AA4-BBC7-B6EF5E2017B1Q34100661-17751912-815C-4270-A279-CD14B18A8B9CQ34457439-9D1D3C1D-DE61-4638-978B-B5136F4C4B33Q35178973-95E4E407-FA66-41D6-B679-8EDAD3666C5DQ36184863-24D09B00-14A7-4C33-8E2F-74F6B9325BBAQ36460550-6872DDE0-1926-4707-97B1-A3DBB7F790C4Q37437839-47D176C4-15B1-4E4D-992E-CE1C680B7BBAQ38045165-A722380D-9222-4601-B9FD-F3897C96BFD2Q38120998-76BF9E99-1011-4774-830F-745813692669Q38153098-80717340-EBFF-45AD-9015-3A8017C9BE4EQ38244346-A3F24401-8AFE-4F10-B6C3-2148F65129E0Q39882072-BA663452-B56B-4C46-9A87-13C7B1756836Q40597331-4CBDD019-458C-4CFD-9065-0575C94BA014Q42382868-124EFEF6-AF5B-451F-AED3-298C67537319Q43203951-0EDFA334-6DE9-47EA-ABBB-DCA1CA7E1AB1Q47228048-319F5C97-8D53-468E-99F8-61C4F9E2B0AEQ47556269-771F5581-2D39-41CC-ACEB-EDF5EC0C1F7DQ47899567-9C14A206-A5E9-4D35-A2E5-1B8B48E3CFA4Q49338688-8EC56EF8-446A-46D4-8DC7-CF6D8CF3CFDAQ50301186-33E072D6-3B8A-4756-9175-A5E44B7E8ABCQ53361310-3D107C28-DF62-4466-8747-F88FD4B39257Q53811350-7337CE44-A764-45E8-A055-9414BFC0696E
P2860
Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
@en
Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
@nl
type
label
Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
@en
Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
@nl
prefLabel
Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
@en
Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
@nl
P2093
P356
P1476
Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
@en
P2093
Cecilia Aström-Lilja
Elisabet Ekman
Johanna Mercke Odeberg
P304
P356
10.1002/PDS.1607
P50
P577
2008-06-01T00:00:00Z